欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3914/001
药品名称Everolimus CF 2.5 mg, tabletten
活性成分
    • everolimus 2.5 mg
剂型Tablet
上市许可持有人STADA Arzneimittel AG Stadast. 2-18 Bad Vilbel 61118 Germany
参考成员国 - 产品名称Netherlands (NL)
Everolimus CF 2.5 mg, tabletten
互认成员国 - 产品名称
    • Germany (DE)
      Everolimus STADA 2,5 mg Tabletten
    • Denmark (DK)
      Everolimus Stada
    • Belgium (BE)
      Everolimus EG 2,5 mg tabletten
    • Luxembourg (LU)
    • Austria (AT)
      Everolimus STADA 2,5 mg Tabletten
    • France (FR)
    • Italy (IT)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
      Everolimus STADA
    • Slovakia (SK)
      EVEROLIMUS STADA 2,5 mg
    • Croatia (HR)
许可日期2018/03/22
最近更新日期2024/01/23
药物ATC编码
    • L01XE10 everolimus
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase